The import of pharmaceutical goods to the UAE in 2023 stood at 31.695 million US dollars. The forecast data shows a gradual decline from 30.778 million US dollars in 2024 to 27.267 million US dollars in 2028. The year-on-year variations indicate a consistent decrease in the import values, with 2024 seeing approximately a -2.89% decrease from 2023, followed by -2.94% in 2025, -2.96% in 2026, -3.00% in 2027, and -3.02% in 2028. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) for imports is approximately -2.96%, indicating a steady decline.
Future trends to watch for include potential increases in local pharmaceutical production, shifts in healthcare policies, and changes in trade regulation that may further impact import values. Additionally, the growing focus on biotechnology and personalized medicine could alter demand dynamics for specific pharmaceutical products in the UAE market.
